FDA Posts Draft Guidance For Drugs to Prevent Kidney Delayed Graft Function

Drug Industry Daily
A A
Because no drugs exist for delayed graft function prevention, the FDA yesterday issued guidance to help foster discussion between drugmakers and the agency on developing drugs to treat the problem.

To View This Article:

Login

Subscribe To Drug Industry Daily